The only available screening tests for ovarian cancer fail to catch early signs of the disease and often result in unnecessary surgery, said researchers at the University of Alabama at…

Annual screening with ultrasound and a blood test called CA 125 usually misses early cases of ovarian cancer, according to a report in the journal Obstetrics and Gynecology. In addition, ovarian cancer…

Treatments used to induce ovulation appear to increase the overall risk of cancer, the results of a study published in the American Journal of Epidemiology suggest.

“Ovulation-inducing drugs are widely used…

Researchers from The University of Texas M. D. Anderson Cancer Center have found that increased angiogenesis, or blood vessel formation, and vascular endothelial growth…

Using cancer cells from an ovarian cancer patient and human embryonic stem cells, Israeli researchers have created a cancerous tumor in a mouse that mimics the way the…

Obese women may have a higher risk of developing ovarian cancer than their thinner counterparts, a large study of U.S. women suggests.

Ovarian cancer is a particularly deadly type of…

Blocking certain proteins in cells may be a way to attack ovarian cancer, researchers said at the annual meeting of the American Society for Cell Biology underway in San Francisco.

In a new analysis of tissue biomarkers expressed in ovarian cancer samples, published by PLoS Medicine, David Huntsman and his colleagues from Vancouver General Hospital suggest that…

Scientists at Johns Hopkins have determined how the characteristic shedding of fatty substances, or lipids, by ovarian tumors allows the cancer to evade the body’s immune system, leaving the…

A new class of compounds called phosphaplatins can effectively kill ovarian, testicular, head and neck cancer cells with potentially less toxicity than conventional drugs, according to a new study published…

A protein known to inhibit the growth of ovarian cancer works in part by forcing cancer cells to eat themselves until they die, researchers at The University of Texas…

An ovarian cancer test being sold the Laboratory Corporation of America (LabCorp) was deemed to have violated the law by the US Food and Drug Administration.

Researchers have identified TEM1 as a specific genetic marker for the vascular cells associated with tumor growth, a finding that could aid in diagnosis and treatment of ovarian cancer.

“The laboratory…

Women with recurrent ovarian cancer can be helped by an experimental therapy using a drug already touted for its ability to fight other cancers, a finding that provides hope…

The regular use of over-the-counter analgesic drugs, such as aspirin and ibuprofen, does not appear to reduce the risk of ovarian cancer, according to findings published in the American…

Scientists from The University of Texas M. D. Anderson Cancer Center have found overexpression of tissue type transglutaminase (TG2) in ovarian cancer is associated with increased tumor…

Women’s reports of persistent, recent-onset symptoms linked to ovarian cancer – abdominal or pelvic pain, difficulty eating or feeling full quickly and abdominal bloating…

Combined positron emission tomography (PET) and computed tomography (CT) scanning of patients in the early stages of ovarian cancer can enable physicians to determine…

A discovery by an East Carolina University pathologist might be a breakthrough in an evolving class of drugs used to fight cancer.

Dr. Anne Kellogg has developed a…

Precision Therapeutics Inc. announced today that the ChemoFx Assay, a cell-based test that examines the response of a specific patient’s tumor to various chemotherapies, correlates…

New research findings from a top clinical investigator at The Cancer Institute of New Jersey (CINJ) indicate the potential for more targeted treatment of ovarian cancer, which is expected to…

A drug that blocks production of an enzyme that enables ovarian cancer to gain a foothold in a new site can slow the spread of the disease…

A protein that stimulates blood vessel growth worsens ovarian cancer, but its production can be stifled by a tiny bit of RNA wrapped in a fatty nanoparticle,…

One of the shortcomings of a therapy that uses millions of identical antibodies to boost the immune system’s attack on cancer cells is that many patients whose tumors recede…

Researchers have developed what they believe is the first blood test that accurately detects ovarian cancer at an early stage.

“The ability to recognize almost 100 percent of new tumors will…